Plastic surgeons say they are seeing more patients seeking treatment for temporal hollowing, a sunken appearance at the temples that can follow rapid facial-volume loss.
The trend has drawn attention during widespread use of GLP-1 medications such as Ozempic and related drugs. The medicines are prescribed for diabetes and, in some cases, weight management; the facial changes are not a diagnosis or expected outcome for every user.
Doctors say weight loss can alter facial-fat distribution, while aging, genetics and the speed of weight loss may also play roles. Patients considering treatment should discuss options and risks with qualified clinicians.
This article was produced with AI assistance and reviewed by BTX Today editors.
Source: USA TODAY, July 31, 2026.
